Dr. Jacob Raphael, M.D.
Anesthesiology (Anesthesiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 124
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anesthesiology Physician primary
PA license MD472910 · VA license 0109542042 -
Pain Medicine (Anesthesiology) Physician
VA license 0101247931
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Thomas Jefferson University Hospital Philadelphia, PA
Medical groups
- Jefferson University Physicians (1,531 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 124
- Services billed
- 307
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Insertion of artery tube for blood sampling or infusion through skin | 33 | 31 |
| Anesthesia for x-ray or radiation therapy | 24 | 24 |
| Ultrasound of heart blood flow, valves and chambers | 21 | 19 |
| Ultrasound of heart with probe in esophagus, with report | 21 | 19 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 15 | 15 |
| Insertion of tube in pulmonary artery for monitoring | 15 | 15 |
| Ultrasonic guidance for blood vessel access | 14 | 14 |
| Anesthesia for procedure on heart and large blood vessels using heart-lung machine and stopping blood flow | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 8 companies reported 27 payments worth $13,940 in total to this clinician.
| Csl Behring | $6,799 |
|---|---|
| Octapharma USA, Inc. | $5,478 |
| Chugai Pharmaceutical Co., LTD. | $1,280 |
| Haemonetics Corporation | $157 |
| Abiomed | $78.31 |
| Werfen USA LLC | $73.89 |
| Atricure, Inc. | $39.29 |
| Surgical Specialties Corporation (US), Inc. (DBA Corza Medical) | $34.90 |
| Compensation for services other than consulting (speaking, faculty) | $5,231 |
|---|---|
| Honoraria | $4,000 |
| Travel and Lodging | $2,347 |
| Consulting Fee | $1,280 |
| Food and Beverage | $1,082 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Csl Behring Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,098 |
| Octapharma USA, Inc. Oct 29, 2025 | Honoraria FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY | $4,000 |
| Chugai Pharmaceutical Co., LTD. Feb 21, 2025 | Consulting Fee | $1,280 |
| Csl Behring Sep 27, 2025 | Travel and Lodging travel to Phoenix, AZ · in-kind | $1,226 |
| Csl Behring Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) in-kind | $1,133 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $268 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $180 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $154 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $146 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $141 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Csl Behring Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,098 |
| Octapharma USA, Inc. Oct 29, 2025 | Honoraria FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY | $4,000 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $268 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $180 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $154 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $146 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $141 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $123 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $70.00 |
| Octapharma USA, Inc. Oct 29, 2025 | Travel and Lodging FIBRYGA & BALFAXAR · INTENSIVE CAREEMERGENCY · travel to PARAMUS, NJ | $38.00 |
| Csl Behring Sep 27, 2025 | Travel and Lodging travel to Phoenix, AZ · in-kind | $1,226 |
| Csl Behring Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) in-kind | $1,133 |
| Chugai Pharmaceutical Co., LTD. Feb 21, 2025 | Consulting Fee | $1,280 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $60,469 in research payments for these studies, mostly to the institutions running them.
- Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Csl Behring · Recruiting · NCT07094087
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.